Introduction
============

Cell endogenous circadian clocks control daily oscillations in behavior, physiology, metabolism, and gene expression. Synchronization with the environment is achieved by external cues, most notably light, but also other factors such as temperature, social interactions, and feeding can provide relevant time information ([@B3]; [@B7]; [@B4]). The molecular oscillators driving circadian outputs share remarkable similarities among different species. In *Drosophila melanogaster*, the key cellular system for circadian timekeeping of sleep-wake cycles is a group of 150 clock neurons residing in the lateral and dorsal brain, which can be further subdivided into several functional distinct groups ([@B21]; [@B10]). All clock neurons harbor a molecular network comprised of several interconnected transcriptional-translational feedback loops where transcription factors induce expression of clock genes, which encode for proteins that act as regulators of their own expression. The central feedback loop consists of the transcription factors Clock (CLK) and Cycle (CYC), which bind to promotor sequences of *timeless (tim)* and *period (per)*. CLK/CYC-mediated *per* and *tim* transcription starts during mid-day and peaks in the evening. PER and TIM proteins accumulate in the cytoplasm of clock cells only at night; here they form heterodimers necessary for translocation into the nucleus where they reach maximum levels toward the end of the night. Once in the nucleus, PER inhibits CLK/CYC activity and therefore *per* and *tim* transcription. Multiple and cooperative phosphorylation events control function, stability, and timely localization of PER and TIM ([@B18]; [@B10]). Briefly, protein kinases Nemo, Doubletime \[DBT, corresponding to vertebrate Casein Kinase1 (CK1)\], Casein Kinase2 (CK2), Shaggy (SGG, the *Drosophila* ortholog of vertebrate GSK3β) and, at least *in vitro*, MAP kinases p38 ([@B11]) and ERK ([@B27]) phosphorylate PER, whereas TIM is the target of CK2 and SGG ([@B54])

An additional serine-threonine kinase regulating circadian rhythmicity in *Drosophila* and vertebrates is p90 Ribosomal S6 Kinase (RSK) ([@B6]; [@B2]). The mechanism through which RSK regulates the molecular clock is still unknown. The single *Drosophila* RSK isoform shows similar homology to each of the four RSK proteins (RSK1--4) found in vertebrates. RSK proteins are characterized by a N-terminal and a C-terminal kinase domain (NTKD, CTKD) joined by a linker domain and a binding site for the MAP kinase ERK located at the C-terminus. Based on biochemical studies, a sequential activation model for RSK proteins was proposed. Upon binding to RSK, ERK phosphorylates and thereby activates the CTKD. ERK- and CTKD-mediated phosphorylation of the linker region generates a binding site for another kinase (PDK1), which subsequently activates the NTKD as the effector kinase for substrate phosphorylation ([@B42]). In this way, RSK proteins mediate ERK signals, but they can also down-regulate ERK by feed-back inhibition. The model of sequential activation was challenged by the finding that *Drosophila* RSK is functional without catalytic activity of the NTKD in the circadian clock ([@B52]).

The identification of multiple interaction partners linked vertebrate RSK proteins to various cellular processes ([@B42]; [@B29]). Notably, loss of RSK2 function in humans causes Coffin--Lowry syndrome (CLS), a rare X-linked disorder, which is associated amongst others with severe intellectual disabilities ([@B38]). Knock-out of *RSK2* in mice uncovered a number of neurophysiological and behavioral phenotypes ([@B39]; [@B37]; [@B8]; [@B32]; [@B34]; [@B14]). Furthermore, elevated RSK activity underlies audiogenic seizure susceptibility in a mouse model for Fragile X-syndrome ([@B45]). In *Drosophila*, RSK acts as a negative regulator of ERK during eye development ([@B26]) and at the larval neuromuscular junction, where it is involved in anterograde axonal transport, synapse formation, and synaptic transmission ([@B15]; [@B5]). Adult *rsk^-^* mutant flies show defects in olfactory, operant and spatial learning as well as shortened circadian periodicity ([@B40]; [@B35]; [@B2]; [@B52]). The observed behavioral deficits do not correlate with obvious structural brain abnormalities. In addition, the question about molecular targets of RSK in flies remains open.

One potential convergence point to explain the pleiotropic functions of RSK in *Drosophila* is the GSK3β ortholog SGG. GSK3β/SGG kinases are part of diverse signaling pathways and have multiple substrate proteins ([@B25]). In vertebrates, a key feature of GSK3β is negative regulation of kinase activity through phosphorylation of a conserved N-terminal located serine residue (S9) by a variety of kinases including AKT, p70S6 Kinase, PKA and RSK ([@B25]). Functional studies in *Drosophila* provided a link between phosphatidylinositol-3-kinase (PI3K)-AKT/Target of Rapamycin (TOR)-p70S6 signaling, SGG-S9 phosphorylation and circadian rhythmicity ([@B55]). SGG phosphorylates Period and Timeless as a major prerequisite for their timely nuclear entry ([@B27]; [@B54]). Correspondingly, modulation of GSK3β/SGG function by overexpression or inhibition changes the phase of the circadian clock ([@B31]; [@B22]).

In this report we wanted to address the question, whether RSK integrates into the molecular circadian clock by regulation of SGG activity. We provide evidence that RSK binds to SGG and phosphorylates S9. Notably, the CTKD but not the NTKD mediates phosphorylation of S9, providing an explanation for previous genetic data ([@B52]) and identifying for the first time an exogenous substrate for the CTKD. Loss of RSK function caused up-regulation of SGG activity in the key pacemaker cells. Genetic interaction studies confirmed the functional relevance of the RSK-SGG interaction to maintain circadian periodicity and to regulate PER expression levels. We suggest that RSK and other kinases determine S9 phosphorylation levels of SGG in clock cells, thereby setting the pace of the molecular circadian oscillator in response to diverse stimuli.

Materials and Methods {#s1}
=====================

Fly Stocks and Genetics
-----------------------

Flies were maintained at 25°C on standard cornmeal food in a 12 h light--dark (LD) cycle. *Canton Special* (*CS*) was the control and genetic background in behavior experiments. Other fly stocks used were as follows: the viable X-chromosomal *rsk* deletion *Df(1)ign*^Δ58/1^ (in the following referred to as *rsk^-^*, [@B40]), *per^01^* ([@B28]), *UAS-sgg* (Bloomington *Drosophila* stock center, Bl-5435), *UAS-sgg-RNAi* (P{TRiP.HMS01751}attP40), Bl-38293) and the null allele *sgg^D127^* (*sgg^-^*, [@B44], kindly provided by Ralf Stanewsky). The *sgg^-^*, *rsk^-^* double mutant was generated by meiotic recombination. Several recombinants were selected on basis of their hemizygous lethality and, when crossed with *rsk^-^* flies, absence of RSK expression on Western blots. The genomic transgene *P\[rsk\]* and the *UAS-rsk* construct were described previously ([@B41]; [@B5]). Clock cells were identified by expression of a *UAS-GFP* reporter construct with the *clk^856^-promotor-Gal4* driver line ([@B17]). For immunostaining, RNA isolation or protein extraction, flies were entrained in a 12 h LD cycle for at least 3 days and then collected at the indicated time points.

Locomotor Activity Recordings and Analysis
------------------------------------------

Locomotor activity of individual virgin female flies (5--7 days old) was recorded using the *Drosophila* Activity Monitor (DAM) system (TriKinetics, Waltham, MA, United States). During the experiment, a medium of agar and sucrose was provided as a food source. Laser beam crossings were counted as single bouts and counts binned in intervals of 1 min. The monitors were placed in boxes and kept at a constant temperature of 20°C. The light source in the box consisted of white LEDs (Lumitronix LED-Technik GmbH, Jungingen, DE) programmed to reach a maximum light intensity of about 100 lux. For evenly adjusting light intensity within the light boxes, neutral density filters were used (Lee Filters Worldwide, Hampshire, United Kingdom). Data were collected using the DAMSystem 2.1.3 software. All flies were entrained for 7 days to photoperiods with 12 h of light per day (LD 12:12) and subsequently released in constant darkness. Individual fly activity was plotted in actograms using the ImageJ plugin ActogramJ ([@B47]). Rhythmicity of individual flies, within the 10 days of recording in DD, was determined using the periodogram analysis tool. In each out of five independent experiments, 15--20 flies were analyzed per genotype.

Immunohistochemistry
--------------------

For immunostainings, adult males were directly collected in fixation solution (4% paraformaldehyde in PBS (10 mM Na~2~HPO~4~, 2 mM KH~2~PO~4~, 2.7 mM KCl, 137 mM NaCl) supplemented with 0.1% Triton X-100). Dissected brains were fixed for 30 min at room temperature, then washed in PBT (PBS plus 0.3% Triton X-100, used for all washing steps) before blocking in PBT supplemented with 5% normal goat serum for 2 h. Incubation with the following primary antibodies was done overnight at 4°C: mouse anti-phospho-Y214-SGG (1:400; clone 5G2F12, [@B36]), rabbit anti-ITP (1:10000, [@B20]), mouse anti-PDF (1:1500, clone C7, Developmental Studies Hybridoma Bank, Iowa City, IA, United States), rabbit anti-PER (1:750, [@B51]) and chicken anti-GFP (1:750; Millipore, Upstate, Temecula, CA, United States). Secondary antibodies were AlexaFluor 488, Cy3 or Cy5-conjugated and were purchased from Molecular Probes (Eugene, OR, United States) and Dianova (Hamburg, DE). Embedding of brains was done in Vectashield (Vector Laboratories, Burlingame, CA, United States) and confocal images were collected with identical settings for all genotypes with a Leica SP5 microscope (Leica Microsystems, Wetzlar, DE). Image processing was carried out in an identical manner with the ImageJ distribution Fiji ([@B46]).

RNA Isolation and RT-qPCR Analysis
----------------------------------

Entrained flies were collected and immediately frozen in liquid nitrogen. Total RNA was extracted from heads using TRIzol^®^ reagent according to the manufacturer's instructions (Ambion^®^, Thermo Fisher Scientific, Waltham, MA, United States). First strand cDNA was synthesized from 2 μg of RNA using High-Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Thermo Fisher Scientific). RT-qPCR was done using PowerUp^TM^ SYBR^TM^ Green Master Mix (Applied Biosystems, Thermo Fisher Scientific) on a StepOnePlus^TM^ (Applied Biosystems, Thermo Fisher Scientific) real-time thermal cycler. Reaction mixtures contained 300 nM of oligonucleotides (see Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). RT-qPCR conditions were 2 min 50°C and 2 min 95°C holding steps, followed by 40 cycles of 15 s 95°C and 1 min at 60°C. Results were expressed as fold change in expression of the treated sample in relation to untreated samples and relative to the reference gene *rp49*. Mean ± SEM was calculated from triplicate experiments from each of the three independent biological samples per genotype.

Bacterial Protein Expression and Purification
---------------------------------------------

For bacterial expression the N-terminal part of SGG (amino acids 1--289) as a GST fusion protein, an EcoRI fragment derived from a *pAC-sgg-V5-His* construct ([@B16]) was cloned into the *pGEX 6P-1* vector (GE Healthcare Life Science, Buckinghamshire, United Kingdom), The resulting construct was used as a template for *in vitro* mutagenesis to replace the TCC triplet encoding serine 9 for GCC (alanine). Primers are listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. All constructs were verified by sequencing. Expression in *E. coli* BL21 (DE3) and GST protein purification were done as described previously ([@B11]). Protein eluates were dialyzed in 20 mM HEPES (pH 7.5) for 48 h.

Cell Culture and Immunoprecipitation
------------------------------------

*Drosophila* Schneider S2 cells were cultured at 25°C in Schneider medium (Biowest, Nuaillé, FR) supplemented with 10% fetal calf serum (FCS), 50 U/ml Penicillin and 50 μg/ml Streptomycin. For transient expression of Myc-epitope tagged RSK in S2 cells, the coding sequence was subcloned from a previously established *pcDNA3-rsk* plasmid ([@B2]) with XbaI-NotI into the *pAc5.1* vector (Invitrogen, Thermo Fisher Scientific) modified with 6xMyc-epitope sequences. Kinase dead versions for the NTKD (RSK^K231M^) and the CTKD (RSK^K597M^) were generated by *in vitro* mutagenesis (oligonucleotide sequences listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). The *pAC-sgg-V5-His* construct was described previously ([@B16]). For transient expression, 4 × 10^6^ cells were suspended in 1 ml FCS free medium and seeded in 6-well plates. Transfection mixtures containing 100 μl FCS free medium, 2 μg DNA and 8 μl Cellfectin (Invitrogen, Thermo Fisher Scientific) were applied to the wells and incubated for 2 h before addition of 2 ml of full medium. After 24 h, medium was replaced with starvation medium (3% FCS) for 24 h to suppress mitogenic signaling. Re-stimulation of cells with full medium was done for 10 min before cells were harvested in PBS for immunoprecipitation. Cells were re-suspended in 500 μl lysis buffer (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EGTA, 2 mM EDTA, 10% Glycerol, 0,5% NP-40) with protease inhibitors (Roche Complete Cocktail and 1 mM AEBSF). Protein complexes were precipitated by overnight incubation with 2 μg anti-Myc antibody (clone 9E10, Santa Cruz Biotech, Dallas, TX, United States) or 10 μg anti His-tag antibody (clone HIS.H8, Thermo Fisher Scientific) bound to 80 μl protein-G-agarose (Roche Diagnostics, Rotkreuz, CH). Samples were washed three times with lysis buffer for Western Blot analysis and additionally with kinase buffer (20 mM HEPES, pH 7.5) for kinase assays.

Western Blot
------------

Lysates from adult heads homogenized and sonicated in 2x Laemmli, cell lysates or immunoprecipitated protein complexes were separated by SDS-PAGE and transferred to PVDF membranes. Blots were incubated overnight at 4°C with the following antibodies: mouse anti-SGG (1:500; clone 4G-1E, Millipore), mouse anti-SGG (1:500, clone 7G1F2, [@B36]), mouse anti-phospho-S9-SGG (1:250; clone 7G2G5, [@B36]), mouse anti-phospho-Y214-SGG (1:250; clone 5G2F12, [@B36]), rabbit anti-GAPDH (1:500, Novus Biologicals, Littleton, CO, United States), rabbit anti-PER (1:10000, [@B51]), mouse anti-Myc (1:1000, clone 9E10, Santa Cruz Biotech.), mouse anti-His-tag antibody (1:2000, clone HIS.H8, Thermo Fisher Scientific), mouse anti-α-Tubulin (1:5000, clone NDM1A, Merck, Darmstadt, DE). After incubation with HRP-coupled secondary antibodies, signal detection was done with the ECL Plus detection reagents (GE Healthcare Life Science) and a ChemoCam ECL Imager equipped with a 16bit camera (Intas, Göttingen, DE). Exposure times were adjusted to allow for quantification of signal intensities within the dynamic range of the camera system.

*In Vitro* Kinase Assay
-----------------------

Kinase reactions were done with non-radioactive ATP. In brief, 15 μg of purified GST::SGG^(1-289)^ or GST::SGG^(1-289)-S9A^ were diluted in 50 μl kinase buffer supplemented with 20 mM MgCl~2~ and 100 μM ATP. After addition of 10 μl of protein G agarose beads complexed with Myc::RSK, Myc::RSK^K231M^ or Myc::RSK^K597M^ proteins, reactions were carried out at 30°C for 30 min and, if indicated, 400U lambda-phosphatase in the provided buffer (New England Biolabs, Ipswich, MA, United States) were added for 90 min at 30°C. Reactions were stopped by adding Laemmli buffer, boiled, separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by Western blot using an antibody directed against phosphorylated S9 in SGG (clone 7G2G5, [@B36]).

Data Analysis
-------------

Statistical analyses were performed using Mann--Whitney-*U*-test (Origin Pro9.0.0 b45 software) to determine significant differences between genotypes. For multiple testing within one data set, the level of significance *p* ≤ 0.05 was adjusted with the Bonferroni correction factor. All graphs are presented as mean ± SEM, asterisks depict level of statistical significance ^∗∗∗^*p* ≤ 0.001, ^∗∗^*p* ≤ 0.01, and ^∗^*p* ≤ 0.05.

Results
=======

RSK Binds to SGG and Phosphorylates Serine 9 in a N-Terminal Kinase Independent Manner
--------------------------------------------------------------------------------------

Biochemical studies in vertebrates identified many interaction partners of RSK proteins, amongst others is protein kinase GSK3β ([@B25]). By contrast, direct downstream targets of *Drosophila* RSK remain so far elusive. RSK, like the *Drosophila* GSK3β homolog SGG, is required for axonal transport, synaptic organization, and circadian behavior ([@B2]; [@B5]) indicating a direct interaction of both kinases. We confirmed this by transient expression of Myc-tagged RSK (Myc::RSK) in Schneider S2 cells and co-immunoprecipitation of Myc::RSK and endogenous SGG (**Figure [1A](#F1){ref-type="fig"}**). Visa versa, immunoprecipitation of transiently expressed His-tagged SGG from S2 cells resulted in co-purification of Myc::RSK (Supplementary Figure [S1](#SM3){ref-type="supplementary-material"}).

![RSK interacts with and phosphorylates SGG at serine 9. **(A)** Lysates from non-transfected Schneider S2 cells (cont) or Myc::RSK transfected cells were directly analyzed by Western blot analysis (lys) or used for immunoprecipitations (IP) with an anti-Myc antibody. The Western blot was probed with anti-Myc and anti-SGG antibodies to detect for co-purification of endogenous SGG. The arrowhead indicates the heavy chain of the anti-Myc antibody from the IP reactions. A representative result from seven independent experiments is shown. **(B)** Input control of bacterially expressed and purified GST::SGG^(1-289)^ or GST::SGG^(1-289)-S9A^ for *in vitro* kinase assays probed with the anti-SGG antibody. Molecular weight markers are indicated. **(C)** RSK C-terminal kinase dependent phosphorylation of SGG at serine 9. Myc::RSK, Myc::RSK^K231M^ and Myc::RSK^K597M^ were immunoprecipitated from transfected S2 cells and used for *in vitro* kinase reactions in the presence of GST::SGG^(1-289)^ or GST::SGG^(1-289)-S9A^ as substrates. Lambda phosphatase treated samples for Myc::RSK in combination with GST::SGG^(1-289)^ or GST::SGG^(1-289)-S9A^ served as controls (lanes 7 and 8). Three independent experiments showed similar results. For uncropped blots, see Supplementary Figure [S3](#SM5){ref-type="supplementary-material"}.](fnmol-11-00122-g001){#F1}

In vertebrates, RSK and other kinases phosphorylate GSK3β at serine 9 (S9) ([@B25]). Correspondingly, previous studies in *Drosophila* demonstrated phosphorylation of SGG at serine 9 ([@B36]). To address the question whether *Drosophila* RSK phosphorylates S9 of SGG, we performed *in vitro* kinase assays using immunoprecipitated Myc::RSK from S2 cells and the bacterially expressed and purified N-terminal part of SGG (GST::SGG^(1-289)^) as a substrate (**Figure [1B](#F1){ref-type="fig"}**). Since we did not know whether RSK is catalytically active under normal growth conditions, we first starved S2 cells and then stimulated MAP-kinase signaling with full medium before immunoprecipitation of Myc::RSK. Using a phospho-S9 specific antibody ([@B36]), phosphorylation of GST::SGG^(1-289)^ was detected (**Figure [1C](#F1){ref-type="fig"}**, lane 1). Lambda phosphatase treatment resulted in disappearance of the signal, confirming the phosphorylation dependent detection of GST::SGG^(1-289)^ with this antibody (**Figure [1C](#F1){ref-type="fig"}**, lane 7). To control for specificity of S9 phosphorylation, we introduced a serine to alanine substitution (S9A) into SGG (GST::SGG^(1-289)-S9A^). Using the same amount of GST::SGG^(1-289)-S9A^ as a substrate for Myc::RSK (**Figure [1B](#F1){ref-type="fig"}**), the phospho-S9 signal was much weaker in comparison to the signal seen with GST::SGG^(1-289)^ (**Figure [1C](#F1){ref-type="fig"}**, lane 2). The remaining weak signal most likely represents co-purified and phosphorylated endogenous SGG, which has a similar molecular weight as the purified GST::SGG proteins. Disappearance of this signal upon phosphatase treatment supported this conclusion (**Figure [1C](#F1){ref-type="fig"}**, lanes 7 and 8).

The sequential activation model of RSK postulates that the N-terminal kinase domain (NTKD) mediates substrate phosphorylation upon preceding activation by the C-terminal kinase (CTKD) ([@B42]). However, recent findings in *Drosophila* demonstrated that NTKD catalytic activity, but not CTKD activity, is dispensable for normal function of RSK in the circadian clock ([@B52]). To resolve this issue for RSK-mediated SGG phosphorylation, we performed *in vitro* kinase assays with variants of RSK carrying either a kinase inactivating substitution in the NTKD (Myc::RSK^K231M^) or the CTKD (Myc::RSK^K597M^). Whereas Myc::RSK^K231M^ is still able to phosphorylate GST::SGG^(1-289)^ to a similar degree than Myc::RSK (**Figure [1C](#F1){ref-type="fig"}**, lane 5), Myc::RSK^K597M^ showed no catalytic activity toward GST::SGG^(1-289)^ (**Figure [1C](#F1){ref-type="fig"}**, lanes 3). Both mutated RSK variants showed no phosphotransferase activity toward GST::SGG^(1-289)-S9A^ (**Figure [1C](#F1){ref-type="fig"}**, lanes 4 and 6).

This experiment provided for the first time evidence that the CTKD can act independent of NTKD catalytic activity to phosphorylate a substrate protein, at least *in vitro*. It also links the NTKD-independent function of RSK in the circadian clock to SGG as one of the central kinases regulating periodicity ([@B31]; [@B52]).

RSK Negatively Regulates SGG Kinase Activity in Adult Brains
------------------------------------------------------------

The direct interaction between RSK and SGG raises the question of the functional relationship *in vivo*. Biochemical studies showed that phosphorylation of serine 9 by several kinases blocks GSK3β kinase activity toward substrate proteins, whereas phosphorylation of a conserved tyrosine residue in the kinase activation loop (Y216 in GSK3β, Y214 in SGG) leads to stimulation of kinase activity ([@B25]). In *Drosophila*, complexity arises by the expression of several SGG isoforms from a single *sgg* transcription unit, among these SGG39 and SGG10 are the most prominent ones. Based on their ability to rescue the lethality of *sgg^-^* mutant animals, functional redundancy of SGG39 and SGG10 was suggested ([@B43]). Furthermore, only these two isoforms contain the conserved S9 phosphorylation site.

To verify a link between RSK, S9 phosphorylation and SGG kinase activity *in vivo*, we first compared overall SGG39 and SGG10 expression levels in adult brains between wild-type, *rsk^-^* mutants, animals overexpressing RSK \[heat-shock promotor (*hsP*)-Gal4 driven *UAS-rsk*\] and *rsk^-^* mutant flies carrying the genomic rescue construct *P\[rsk\]*. Quantification of signal intensities normalized to the loading control showed that neither loss nor overexpression of RSK had an influence on overall SGG10 and SGG39 levels (**Figure [2A](#F2){ref-type="fig"}**). SGG kinase activity levels were monitored with an antibody directed against phosphorylated Y214-SGG (pY214-SGG, [@B36]) and normalized to overall SGG levels. *RSK^-^* mutant flies showed a slight but significant increase in Y214 phosphorylation, a phenotype that reverted back to wild-type levels upon expression of the genomic rescue construct (**Figure [2B](#F2){ref-type="fig"}**). Conversely, *hsP-Gal4* induced expression of the *UAS-rsk* transgene in an *rsk^-^* mutant background resulted in a strong reduction of Y214 phosphorylation (**Figure [2B](#F2){ref-type="fig"}**). These results indicated that RSK has a negative influence on SGG activity. Based on biochemical evidence this should be mediated by phosphorylation of serine 9. Indeed, up-regulation of SGG activity in *rsk^-^* (**Figure [2B](#F2){ref-type="fig"}**) correlated with a decreased pS9-SGG signal (**Figure [2C](#F2){ref-type="fig"}**). Under over-expression conditions in an *rsk^-^* background, pS9-SGG levels raised as expected but did not exceed values of the wild-type or rescue controls (**Figure [2C](#F2){ref-type="fig"}**). At first sight, this was unexpected because of decreased pY214-SGG levels under over-expression conditions (**Figure [2B](#F2){ref-type="fig"}**). Since negative regulation is a key feature of SGG/GSK3β proteins ([@B25]), S9 phosphorylation levels should be high in order to restrict SGG activation in space and time to specific stimuli. RSK overexpression permanently maintains high S9 phosphorylation, thereby making SGG less responsive for activation, which is reflected by lower pY214 levels (**Figure [2B](#F2){ref-type="fig"}**).

![RSK negatively influences SGG activity *in vivo.* Protein lysates from heads of wild-type, RSK loss (*rsk^-^*), RSK overexpression (*rsk^-^; hsP-Gal4; UAS-rsk*) or RSK rescue (*rsk^-^;P\[rsk\]*) flies were extracted at ZT8 and analyzed for total expression levels of the SGG10 and SGG39 isoforms **(A)**, phospho-Y214-SGG **(B)**, and phospho-S9-SGG **(C)**. Representative Western blots are shown. The bars in the graphs below show the combined band intensity values for SGG10 and SGG39 from five independent biological replicates for all genotypes. Each replicate was independently analyzed. **(A)** To determine relative pan-SGG levels, the house keeping protein GAPDH was used as a reference for normalization and the value for wild-type was set to the arbitrary unit 1. Phospho-Y214-SGG **(B)** and phospho-S9-SGG **(C)** were first normalized to GAPDH and then to the corresponding pan-SGG value for each genotype. Values are presented as relative amount compared to the arbitrary wild-type value 1. For uncropped blots, see Supplementary Figure [S4](#SM6){ref-type="supplementary-material"}.](fnmol-11-00122-g002){#F2}

A Functional Link Between RSK and SGG to Control Circadian Periodicity
----------------------------------------------------------------------

The influence of RSK on SGG activity suggested that the circadian phenotype of *rsk^-^* mutants is caused by de-regulation of SGG. To address this point we performed genetic interaction experiments and immunostainings.

Male flies carrying a deletion of the X-chromosomal *rsk^-^* transcription unit have a shortened circadian period of about 23 h ([@B2]; [@B52]). Because our analysis required female flies, we first verified the short period phenotype in female *rsk^-^* animals (wild-type: 23.92 ± 0.065, *rsk^-^*: 23.27 ± 0.065, *p* \< 0.001) (**Figures [3A,B,F](#F3){ref-type="fig"}**). Introducing the genomic *rsk* transgene in the *rsk^-^* background reverted the phenotype to wild-type values (*rsk^-^, P\[rsk\]*: 23.82 ± 0.061, *p* = 0.33 vs. wild-type) (**Figures [3C,F](#F3){ref-type="fig"}**).

![Cooperation of RSK and SGG to regulate circadian periodicity. **(A--E)** Shown are actograms from individual flies of the indicated genotypes trained under 12:12 h light--dark (LD, indicated by white and black bars) before testing them in constant darkness (DD). **(F)** Comparison of period lengths. Data represent the combination of two independent experiments with the number of analyzed flies shown in the bars.](fnmol-11-00122-g003){#F3}

To test for a functional link of RSK and SGG to maintain circadian periodicity, we used the recessive lethal loss-of-function allele *sgg^D127^* (*sgg^-^*). Previous studies showed that elimination of SGG function only in the adult resulted in a pronounced long period phenotype caused by delayed PER/TIM nuclear entry ([@B31]). Confirmation came from mutation of relevant SGG phosphorylation sites in TIM and PER ([@B27]; [@B54]). Heterozygous *sgg^-^*/+ animals showed normal periodicity (*sgg^-^/+*: 24.03 ± 0,026, *p* \< 0.001 vs. *rsk^-^* (**Figures [3D,F](#F3){ref-type="fig"}**). If RSK functions as a negative regulator of SGG kinase activity in the molecular clock, the *rsk^-^* short period phenotype could be caused by enhanced SGG-mediated phosphorylation of PER/TIM, which would promote nuclear entry. If this model is correct, then reducing SGG expression levels by heterozygous *sgg^-^* mutation should counteract enhanced SGG kinase activity in homozygous *rsk^-^* mutants and thereby the short-period phenotype should be at least attenuated. To test this model, X-chromosomal *sgg^-^, rsk^-^* double mutant fly lines were established and crossed with *rsk^-^* flies. Female progeny flies (*sgg^-^, rsk^-^*/*rsk^-^*) showed a periodicity not significantly different from *sgg^-^/+* animals (*sgg^-^, rsk^-^*/*rsk^-^*: 24.09 ± 0.035, *p* \< 0.001 vs. *rsk^-^*; *p* = 0.07 vs. *sgg^-^/+*) (**Figures [3B,D--F](#F3){ref-type="fig"}**) indicating that RSK integrates into the molecular oscillator mainly by negative regulation of SGG activity. Confirmation of this result came from analysis of a second, independent *sgg^-^, rsk^-^* recombinant (data not shown).

Since SGG activity specifically in small (s-)LN~v~ is critical for normal rhythmicity under constant conditions ([@B54]), we focused to this group of clock neurons for further analysis. Clock neurons are subdivided in three groups of dorsal neurons (DN~1-3~) and four groups of lateral neurons \[LPN, LN~d~ + 5^th^ LN~v~, large (l-)LN~v~ and s-LN~v~\]. These cells express the core clock components, but are functionally distinct with the LN~d~ + 5^th^ LN~v~ and the s-LN~v~ considered as the main circadian pacemaker cells controlling morning and evening activity of the flies ([@B21]; [@B10]; [@B19]; [@B49]).

Because of the potential function of RSK in cellular differentiation, we first excluded the possibility that loss of RSK affects the clock neuron network. Stainings against the neuropeptides PDF and ITP verified the presence of l-LN~v~, s-LN~v~, 5^th^ LN~v~ and LN~d~ in *rsk^-^* with no obvious changes in their arborization patterns when compared to wild-type (**Figure [4A](#F4){ref-type="fig"}**). The initial attempts to directly monitor the influence of RSK on S9 phosphorylation of SGG in s-LN~v~ using the same antibody as for Western blot analysis provided no reliable signals. Therefore, we used the pY214-SGG antibody as an indicator for SGG kinase activity. The time point chosen for analysis was ZT20, when SGG kinase activity should be high to allow PER/TIM phosphorylation and nuclear entry ([@B50]). The pY214-SGG antibody labeled the entire brain neuropil and the cytoplasm of the cell bodies, which is consistent with the pleiotropic roles of SGG/GSK3β in different cellular signaling processes, axonal transport and synaptic function ([@B25]). In wild-type animals, cytoplasmic pY214-SGG staining in s-LN~v~ was only slightly higher than in the surrounding tissue (**Figure [4B](#F4){ref-type="fig"}**). By contrast, s-LN~v~ of *rsk^-^* animals showed significantly elevated pY214-SGG staining (**Figures [4B,C](#F4){ref-type="fig"}**). To verify specificity of the pY214-SGG antibody, we performed *sgg* knock-down and overexpression experiments in clock neurons (Supplementary Figure [S2](#SM4){ref-type="supplementary-material"}). SGG overexpression resulted in elevated pY214-SGG signals in s-LN~v~ (Supplementary Figure [S2A](#SM4){ref-type="supplementary-material"}), whereas *sgg* knock-down caused cell swelling, collapse of l-LN~v~ arborizations (Supplementary Figure [S2B](#SM4){ref-type="supplementary-material"}) and complete disappearance of s-LN~v~. Based on position, few cells could be considered as s-LN~v~, but they were misshaped and either showed no or homogenous PER and residual pY214-SGG staining (Supplementary Figure [S2A](#SM4){ref-type="supplementary-material"}).

![Elevated SGG activity in s-LN~v~ in *rsk^-^* mutants. **(A)** Analysis of the l-LN~v~ and s-LN~v~ arborization patterns in *rsk^-^* by staining for neuropeptide PDF expressed in s-LN~v~ (excluding the 5^th^ LN~v~) and l-LN~v~ (for wild-type see Supplementary Figure [S2B](#SM4){ref-type="supplementary-material"}) and ITP, which is restricted to the 5^th^ LN~v~ and a single LN~d~ ([@B21]). Asterisks: ITP positive non-clock neurons. Scale bar 20 μm. **(B)** s-LN~v~ in wild-type or *rsk^-^* mutants were identified by position and expression of a GFP-reporter under the control of *clk^856^*-Gal4 driver line. Brains were stained at ZT20 for GFP, PER and activated SGG (pY214-SGG). Pictures are representative examples from at least eight brains analyzed per genotype, recorded and processed in an identical manner. Scale bar: 5 μm. **(C)** Quantification of pY214-SGG signal intensities in s-LN~v~ of *rsk^-^* (*n* = 33 cells in eight brains) compared to wild-type (*n* = 31 cells in eight brains). The pY214-SGG signal in each cell was first normalized to the corresponding GFP-signal and the combined values for wild-type were set to the arbitrary unit 1.](fnmol-11-00122-g004){#F4}

In summary, we propose a function of RSK as a negative regulator of SGG kinase activity in s-LN~v~. The short-period phenotype of *rsk^-^* flies can be explained by enhanced SGG-mediated phosphorylation of PER/TIM resulting in precocious nuclear entry. However, the small differences in circadian period in *rsk^-^* did not allow us to detect changes in the localization profile of PER/TIM by immunohistochemical stainings.

SGG Mediates the Effect of RSK on *per* Transcription and PER Protein Levels
----------------------------------------------------------------------------

PER protein undergoes daily oscillations in abundance and phosphorylation with peak levels found at late night ([@B12]) resulting in feedback repression of CLK/CYC-mediated *per* transcription ([@B33]). Previous studies demonstrated enhanced PER protein levels in *rsk^-^* animals, which are associated with increased feedback repression of *per* transcription ([@B2]). These results left open the question whether SGG acts as a mediator for RSK to regulate *per* transcription and PER protein levels.

First, we recapitulated these findings by RT-qPCR analyses of *per* mRNA isolated from head extracts of wild-type and *rsk^-^* flies reared under LD conditions. *per* mRNA levels raise during day and reach peak levels at early night before they drop as a consequence of PER feedback inhibition. Compared to controls, *per* mRNA in *rsk^-^* showed the same periodicity but transcription levels are reduced at most time points (**Figure [5A](#F5){ref-type="fig"}**). Introducing the genomic *P\[rsk\]* transgene largely reverted the decrease in *per* mRNA in *rsk^-^* to wild-type values (**Figure [5A](#F5){ref-type="fig"}**). At the protein level, we analyzed PER expression levels by Western blot at ZT16, when PER accumulates in the cytoplasm thus allowing high CLK/CYC-driven *per* transcription and at ZT20, when nuclear PER mediates feedback repression. At both time points, loss of RSK function resulted in elevated levels of PER compared to wild-type (**Figures [5B,C](#F5){ref-type="fig"}**). The *P\[rsk\]* transgene significantly reduced PER levels, but rescue was not complete (**Figures [5B,C](#F5){ref-type="fig"}**).

![RSK and SGG cooperate to regulate PER-mediated transcriptional feedback repression and PER levels. **(A)** Circadian oscillation of *per* mRNA levels compared between wild-type, *rsk^-^*, *rsk^-^; P\[rsk\]* and *sgg^-^*, *rsk^-^*/*rsk^-^*. The plot represents the sum of three biological replicates, each repeated in triplicate. *rp49* was used as an internal control to normalize transcript levels. Data points are means ± SEM. **(B,C)** Representative Western blots of adult fly head extracts of the indicated genotypes at ZT 16 **(B)** and ZT20 **(C)** probed for PER and α-Tubulin as a loading control. *per^01^* served as a negative control. Graphs represent measurements of PER levels from four biological replicates normalized to α-Tubulin (mean ± SEM). For uncropped blots, see Supplementary Figure [S5](#SM7){ref-type="supplementary-material"}.](fnmol-11-00122-g005){#F5}

If SGG acts as a mediator for RSK to regulate *per* transcription and PER protein levels, reducing the gene dose of *sgg* by half in *sgg^-^, rsk^-^*/*rsk^-^* animals should at least partially suppress excessive accumulation of PER in *rsk^-^* and, as a consequence, increased feedback repression of *per* transcription should be relieved. Indeed, *per* mRNA levels increased close to wild-type values for most time points tested (**Figure [5A](#F5){ref-type="fig"}**). At the protein level, PER was significantly reduced compared to *rsk^-^* (**Figures [5B,C](#F5){ref-type="fig"}**). This corresponds to the largely normal transcriptional profile of *per* in *sgg^-^, rsk^-^*/*rsk^-^* animals and correlates with normal circadian behavior (**Figures [3E,F](#F3){ref-type="fig"}**, **[5A](#F5){ref-type="fig"}**). As a major conclusion we provided evidence that RSK influences feedback repression of *per/tim* transcription by modulating SGG function.

Discussion
==========

Previous studies showed that clock cells in flies require RSK to perform normal periodicity ([@B2]), but the molecular mechanism through which the kinase modulates the circadian clock remained elusive. Our biochemical and genetic experiments now provide evidence that RSK negatively regulates kinase activity of the central clock kinase SGG by phosphorylation of serine 9. Notably, we identified SGG as an exogenous substrate of the C-terminal kinase domain of RSK. So far, biochemical studies in vertebrates only verified a function of the C-terminal kinase domain as an intramolecular activator of the N-terminal kinase domain ([@B42]). Yet, our finding is in line with previous behavioral studies in flies showing that RSK function in the circadian clock requires a functional C-terminal kinase domain, whereas catalytic activity of the N-terminal kinase domain is dispensable ([@B52]). Notably, during *Drosophila* eye and wing development, RSK acts as a cytoplasmic anchor for ERK and this function is independent of catalytic activity of both kinase domains ([@B26]). This indicates that the necessity of functional kinase domains in RSK is cellular context dependent.

SGG phosphorylates PER and TIM to finally promote their timely co-translocation to the nucleus ([@B31]). Increased SGG activity in *rsk^-^* mutants should promote accumulation of phosphorylated PER/TIM complexes and their accelerated entry into the nucleus, which explains the *rsk^-^* short period phenotype under DD conditions. However, given the pronounced circadian phenotypes under SGG overexpression or loss of function conditions ([@B31]), the minor effect of *rsk^-^* on periodicity argues for a modulatory rather than a mandatory role of RSK to control SGG activity. Indeed, also AKT/TOR signaling mediates S9-SGG phosphorylation thereby linking metabolic pathways and circadian behavior ([@B53]; [@B55]). We therefore consider phosphorylation of S9-SGG as a central convergence point for diverse environmental and physiological stimuli to adapt circadian behavior.

Since all clock neurons harbor a molecular oscillator, it is possible that RSK mediated regulation of SGG in maintaining normal free-running rhythm might play a role in more than one clock neuron cluster. Several experiments support the conclusion that the interaction of RSK with SGG in s-LN~v~ plays a central role to maintain periodicity. First, expression of an *rsk* transgene specifically in PDF-expressing neurons (s-LN~v~ and l-LN~v~) rescued the *rsk^-^* short period phenotype ([@B2]). Second, overexpression of SGG in s-LN~v~, but not in l-LN~v~ caused a short period phenotype indicating that regulation of SGG activity in s-LNs is essential for normal periodicity ([@B54]). The enhanced SGG activity in s-LN~v~ in *rsk^-^* supports this conclusion (**Figure [4](#F4){ref-type="fig"}**). However, the Western blot analysis from whole brain lysates indicated a global up-regulation of SGG activity in *rsk^-^* (**Figure [2](#F2){ref-type="fig"}**), which is consistent with the pleiotropic functions of RSK in ERK signaling ([@B42]) and of SGG/GSK3β in the Wingless/Wnt pathway ([@B25]). Although molecular oscillators act cell-autonomously, recent evidence suggestedcomplex cross-talks and feedback-loops among clock neurons to maintain periodicity ([@B9]). Also glia cells integrate into the circadian network ([@B23]). Thus a rigorous test for a functional link between RSK and SGG solely in s-LNv to maintain normal periodicity is necessary. However, the observed cell damages upon *sgg* knock-down impede such an analysis (Supplementary Figure [S2B](#SM4){ref-type="supplementary-material"}).

Could there be alternative routes how RSK acts on SGG to influence PER or TIM? SGG-mediated phosphorylation of PER at serine 657 residue requires preceding phosphorylation of the neighboring serine 661 residue. The MAP-kinases ERK and p38 promote serine 661 phosphorylation ([@B27]; [@B11]) and thus RSK as a downstream effector of ERK might be the relevant kinase. We exclude a function of RSK as a serine 661phosphorylating kinase for two reasons. First, *in vitro* biochemical data suggested direct phosphorylation by ERK or p38 ([@B27]; [@B11]). Second, abrogation of serine 657 or 661 phosphorylation by alanine substitutions resulted in delayed nuclear entry of PER, period lengthening and decreased feedback repression of *per* transcription ([@B27]). By contrary, loss of RSK causes shortened periodicity and increased feedback repression of *per* transcription, which is not consistent with a function of RSK as a S661 phosphorylating kinase. However, RSK not only acts as an effector of ERK, but negatively regulates ERK activity by feedback inhibition ([@B42]). Future studies have to clarify the issue, whether fine tuning of ERK activity by RSK in clock neurons is an additional mechanism.

Our results also help to resolve the conundrum about the relationship between RSK and kinase CK2 in clock cells. CK2 is a heterotetrameric kinase expressed in all eukaryotic cells with a vast array of substrates ([@B13]). Mutations in the *Drosophila* CK2 subunits result in period lengthening due to impaired PER/TIM phosphorylation and delayed nuclear entry ([@B30]; [@B1]). Double mutant combinations of the "short period" *rsk^-^* mutant and the "long period" *CK2* mutants showed a similar long periodicity than the single *CK2* mutants suggesting a model where RSK negatively regulates CK2 activity ([@B2]). However, such a model is difficult to reconcile with biochemical and structural data implicating CK2 as a kinase that is not regulated by second messengers ([@B48]). Based on a recent study showing that CK2-mediated phosphorylation of TIM requires preceding phosphorylation of TIM by SGG ([@B54]), we can now reconcile the conflicting genetic and biochemical data. RSK is a negative regulator of SGG activity, which is required for CK2-mediated phosphorylation of TIM and nuclear entry (**Figure [6](#F6){ref-type="fig"}**). The model predicts that in *rsk^-^* mutants, elevated SGG activity promotes CK2-mediated phosphorylation of TIM and advanced nuclear entry. In *rsk^-^ CK2* double mutants, CK2-mediated phosphorylation of TIM is impaired. Therefore, these flies have a similar long period phenotype than the *CK2* single mutants, despite enhanced SGG activity caused by lack of RSK.

![Model of RSK function in the circadian clock. The model relies on previous data demonstrating the hierarchical action of MAP-kinases and SGG on PER ([@B27]; [@B11]) respectively SGG and CK2 on TIM ([@B54]). For simplicity, DBT, CK2 and Nemo-mediated phosphorylation of PER was omitted. SGG is kept in an inactive conformation by phosphorylation of S9. Release of this inhibition promotes nuclear entry of PER/TIM complexes and feedback transcriptional repression. For details, see section "Discussion."](fnmol-11-00122-g006){#F6}

In summary we propose that RSK has effects on PER and TIM. The hierarchical cascade of RSK-SGG-CK2 controls TIM-dependent nuclear entry of TIM/PER complexes ([@B24]), whereas RSK-SGG influence the transcriptional repressive function of PER. Since regulation of SGG activity by RSK and other kinases is at the center of both processes, defining the upstream signals for these kinases will provide important information how changes in environmental or physiological condition are translated into appropriate circadian behavioral responses. Furthermore, RSK in *Drosophila* and RSK2 in vertebrates influence a variety of behavioral responses and regulate synaptic function. It will be interesting to investigate a putative RSK-SGG/GSK3β link in a broader neuronal context. With this knowledge our understanding of the pathophysiology of Coffin--Lowry syndrome can be improved.
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